Alternatives to Nucleai

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.